Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells

Basic Research in Cardiology

Volumn 108, Issue 4, 2013, Pages

  Korten, Slobodanka ^a,b   Brunssen, Coy ^a   Poitz, David M ^c   Großklaus, Sylvia ^d   Brux, Melanie ^a   Schnittler, Hans Joachim ^b,d,e   Strasser, Ruth H ^b,c   Bornstein, Stefan R ^a,b   Morawietz, Henning ^a,b   Goettsch, Winfried ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c University Heart Center Dresden   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Arteriovenous differentiation; COUP TFII; Endothelial cells; Hey2; Vascular biology

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; DELTA LIKE 1 PROTEIN; DELTA LIKE 4 PROTEIN; EPHRIN; EPHRIN B2; EPHRIN B4; HERMES ANTIGEN; JAGGED1; LENTIVIRUS VECTOR; NEUROPILIN 1; NOTCH4 RECEPTOR; PRESENILIN 1; PRESENILIN 2; PROTEIN; SHORT HAIRPIN RNA; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HEY1; TRANSCRIPTION FACTOR HEY2; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ARTERY ENDOTHELIUM CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; COUP TFII GENE; DOWN REGULATION; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; HEY2 GENE; HUMAN; HUMAN CELL; MARKER GENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; UMBILICAL ARTERY; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VEIN ENDOTHELIUM CELL;

EID: 84878447005     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0362-0     Document Type: Article

References (33)

1. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100:10623-10628. doi: 10.1073/pnas.1434429100 (Pubitemid 37140079)
2. Covassin LD, Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND (2006) Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA 103:6554-6559. doi: 10.1073/pnas.0506886103
3. Deng DX, Tsalenko A, Vailaya A, Ben-Dor A, Kundu R, Estay I, Tabibiazar R, Kincaid R, Yakhini Z, Bruhn L, Quertermous T (2006) Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli. Circ Res 98:200-208. doi: 10.1161/01.RES.0000200738.50997. f2
4. Doetzlhofer A, Basch ML, Ohyama T, Gessler M, Groves AK, Segil N (2009) Hey2 regulation by FGF provides a Notch-independent mechanism for maintaining pillar cell fate in the organ of Corti. Dev Cell 16:58-69. doi: 10.1016/j.devcel.2008.11.008
5. Donovan J, Kordylewska A, Jan YN, Utset MF (2002) Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12:1605-1610 (pii:S0960982202011491)
6. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911. doi: 10.1101/gad.29100418/8/901 (Pubitemid 38529659)
7. Gessler M, Knobeloch KP, Helisch A, Amann K, Schumacher N, Rohde E, Fischer A, Leimeister C (2002) Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol 12:1601-1604. doi: S0960982202011508
8. Goettsch C, Goettsch W, Brux M, Haschke C, Brunssen C, Muller G, Bornstein SR, Duerrschmidt N, Wagner AH, Morawietz H (2011) Arterial flow reduces oxidative stress via an antioxidant response element and Oct-1 binding site within the NADPH oxidase 4 promoter in endothelial cells. Basic Res Cardiol 106:551-561. doi: 10.1007/s00395-011-0170-3
9. Goettsch C, Goettsch W, Muller G, Seebach J, Schnittler HJ, Morawietz H (2009) Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun 380:355-360. doi: 10.1016/j.bbrc.2009.01.107
10. Goettsch W, Gryczka C, Korff T, Ernst E, Goettsch C, Seebach J, Schnittler HJ, Augustin HG, Morawietz H (2008) Flow-dependent regulation of angiopoietin-2. J Cell Physiol 214:491-503. doi: 10.1002/jcp.21229 (Pubitemid 350309006)
11. Guha S, Cullen JP, Morrow D, Colombo A, Lally C, Walls D, Redmond EM, Cahill PA (2011) Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival. Basic Res Cardiol 106:773-785. doi: 10.1007/s00395-011-0189-5
12. Ho M, Yang E, Matcuk G, Deng D, Sampas N, Tsalenko A, Tabibiazar R, Zhang Y, Chen M, Talbi S, Ho YD, Wang J, Tsao PS, Ben-Dor A, Yakhini Z, Bruhn L, Quertermous T (2003) Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 13:249-262. doi: 10.1152/physiolgenomics.00186.2002 (Pubitemid 37129190)
13. Iso T, Hamamori Y, Kedes L (2003) Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23:543-553. doi: 10.1161/01.ATV. 0000060892.81529.8F (Pubitemid 36438065)
14. Kang J, Yoo J, Lee S, Tang W, Aguilar B, Ramu S, Choi I, Otu HH, Shin JW, Dotto GP, Koh CJ, Detmar M, Hong YK (2010) An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood 116:140-150. doi: 10.1182/blood-2009-11- 252270
15. Korff T, Dandekar G, Pfaff D, Fuller T, Goettsch W, Morawietz H, Schaffner F, Augustin HG (2006) Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31. Arterioscler Thromb Vasc Biol 26:468-474. doi: 10.1161/01.ATV.0000200081.42064. e7
16. Kroller-Schon S, Schulz E, Wenzel P, Kleschyov AL, Hortmann M, Torzewski M, Oelze M, Renne T, Daiber A, Munzel T (2011) Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res Cardiol 106:1147-1158. doi: 10.1007/s00395-011-0227- 3
17. Kronstein R, Seebach J, Grossklaus S, Minten C, Engelhardt B, Drab M, Liebner S, Arsenijevic Y, Taha AA, Afanasieva T, Schnittler HJ (2011) Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res 93:130-140. doi: 10.1093/cvr/cvr256
18. Kume T (2010) Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 25:637-646
19. Lanner F, Sohl M, Farnebo F (2007) Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler Thromb Vasc Biol 27:487-493. doi: 10.1161/01.ATV.0000255990.91805.6d
20. Lehle K, Straub RH, Morawietz H, Kunz-Schughart LA (2010) Relevance of disease- and organ-specific endothelial cells for in vitro research. Cell Biol Int 34:1231-1238. doi: 10.1042/CBI20100531
21. Masumura T, Yamamoto K, Shimizu N, Obi S, Ando J (2009) Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler Thromb Vasc Biol 29:2125-2131. doi: 10.1161/ATVBAHA.109.193185
22. Morawietz H (2011) Endothelial NADPH oxidases: friends or foes? Basic Res Cardiol 106:521-525. doi: 10.1007/s00395-011-0188-6
23. Murdoch CE, Alom-Ruiz SP, Wang M, Zhang M, Walker S, Yu B, Brewer A, Shah AM (2011) Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res Cardiol 106:527-538. doi: 10.1007/s00395-011-0179-7
24. Park Y, Yang J, Zhang H, Chen X, Zhang C (2011) Effect of PAR2 in regulating TNF-alpha and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice. Basic Res Cardiol 106:111-123. doi: 10.1007/s00395-010-0129-9
25. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY (1999) The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 13:1037-1049 (Pubitemid 29200986)
26. Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21:2511-2524. doi: 10.1101/gad.1589207 (Pubitemid 47607663)
27. Sakata Y, Kamei CN, Nakagami H, Bronson R, Liao JK, Chin MT (2002) Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci USA 99:16197-16202. doi: 10.1073/pnas.252648999 (Pubitemid 35462772)
28. Sirker A, Zhang M, Shah AM (2011) NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106:735-747. doi: 10.1007/s00395-011-0190-z
29. Sorensen I, Adams RH, Gossler A (2009) DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113:5680-5688. doi: 10.1182/blood-2008-08-174508
30. Swift MR, Weinstein BM (2009) Arterial-venous specification during development. Circ Res 104:576-588. doi: 10.1161/CIRCRESAHA.108.188805
31. Tiyerili V, Zimmer S, Jung S, Wassmann K, Naehle CP, Lutjohann D, Zimmer A, Nickenig G, Wassmann S (2010) CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol 105:465-477. doi: 10.1007/s00395-010- 0090-7
32. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104. doi: 10.1038/nature03511 (Pubitemid 40655915)
33. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC (2000) gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287:1820-1824. doi: 8344 (Pubitemid 30143966)